126 related articles for article (PubMed ID: 23931214)
1. Re: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Kaplan SA
J Urol; 2013 Sep; 190(3):978. PubMed ID: 23931214
[No Abstract] [Full Text] [Related]
2. Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Öztürk Mİ; Kalkan S; Koca O; Güneş M; Akyüz M; Karaman MI
Andrologia; 2012 May; 44 Suppl 1():791-5. PubMed ID: 22211956
[TBL] [Abstract][Full Text] [Related]
3. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Kaplan SA; Gonzalez RR; Te AE
Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
[TBL] [Abstract][Full Text] [Related]
4. Re: Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial: K. T. McVary, W. Monnig, J. L. Camps, Jr., J. M. Young, L. J. Tseng and G. van den Ende. J Urol 2007; 177: 1071-1077.
Ponholzer A; Rauchenwald M; Madersbacher S
J Urol; 2007 Sep; 178(3 Pt 1):1121-2; author reply 1122-3. PubMed ID: 17640682
[No Abstract] [Full Text] [Related]
5. Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?
Sciarra A
Eur Urol; 2007 Jun; 51(6):1485-7. PubMed ID: 17275984
[No Abstract] [Full Text] [Related]
6. [The positive effect of sildenafil on LUTS from BPH while treating ED].
Ying J; Yao D; Jiang Y; Ren X; Xu M
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
[TBL] [Abstract][Full Text] [Related]
7. [LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Praus F; Miernik A
Urologe A; 2019 Jul; 58(7):795-798. PubMed ID: 31143977
[No Abstract] [Full Text] [Related]
8. Male lower urinary tract symptoms and sildenafil.
Jackson G
Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
[No Abstract] [Full Text] [Related]
9. Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects.
MacDonald R; Wilt TJ
Urology; 2005 Oct; 66(4):780-8. PubMed ID: 16230138
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.
Gales BJ; Gales MA
Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of prostatic adenoma treatment with alfusozine depending on sexuality].
Kogan MI; Kireev AIu
Urologiia; 2011; (1):28-31. PubMed ID: 21500491
[TBL] [Abstract][Full Text] [Related]
12. An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia.
Kim MK; Cheon J; Lee KS; Chung MK; Lee JY; Lee SW; Kim SW; Chung BH; Park K; Park JK
Int J Clin Pract; 2010 Feb; 64(3):345-50. PubMed ID: 19891715
[TBL] [Abstract][Full Text] [Related]
13. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
[TBL] [Abstract][Full Text] [Related]
14. Novel treatments for men with lower urinary tract symptoms suggestive of benign prostate hyperplasia.
Chung SD; Yu HJ
J Formos Med Assoc; 2009 May; 108(5):349-52. PubMed ID: 19443288
[No Abstract] [Full Text] [Related]
15. A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Gacci M; Vittori G; Tosi N; Siena G; Rossetti MA; Lapini A; Vignozzi L; Serni S; Maggi M; Carini M
J Sex Med; 2012 Jun; 9(6):1624-33. PubMed ID: 22510238
[TBL] [Abstract][Full Text] [Related]
16. How many drugs for LUTS due to BPH are too many?
Andersson KE
J Urol; 2008 Sep; 180(3):811-2. PubMed ID: 18635235
[No Abstract] [Full Text] [Related]
17. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
Carson CC
BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
[TBL] [Abstract][Full Text] [Related]
18. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
[TBL] [Abstract][Full Text] [Related]
19. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
Güler C; Tüzel E; Doğantekin E; Kiziltepe G
Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
[TBL] [Abstract][Full Text] [Related]
20. Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?
Morgia G
Eur Urol; 2011 Mar; 59(3):353-5; discussion 355. PubMed ID: 21130562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
